Page last updated: 2024-11-08

serine and Ataxia Telangiectasia

serine has been researched along with Ataxia Telangiectasia in 22 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Ataxia Telangiectasia: An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).

Research Excerpts

ExcerptRelevanceReference
"Treatment with lactacystin (an inhibitor of the proteasome) or heat shock leads to similar levels of p53 accumulation in normal and AT fibroblasts, but the p53 protein lacks a phosphorylated serine 15."1.30Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. ( Nakagawa, K; Tamai, K; Taya, Y; Yamaizumi, M, 1999)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (13.64)18.2507
2000's17 (77.27)29.6817
2010's2 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
von Morgen, P1
Burdova, K1
Flower, TG1
O'Reilly, NJ1
Boulton, SJ1
Smerdon, SJ1
Macurek, L1
Hořejší, Z1
Gatei, M2
Kijas, AW1
Biard, D1
Dörk, T1
Lavin, MF2
Das, BB1
Antony, S1
Gupta, S1
Dexheimer, TS1
Redon, CE1
Garfield, S1
Shiloh, Y3
Pommier, Y1
Sutton, IJ1
Last, JI2
Ritchie, SJ1
Harrington, HJ1
Byrd, PJ2
Taylor, AM2
Goodarzi, AA2
Lees-Miller, SP2
Jonnalagadda, JC1
Douglas, P1
Young, D1
Ye, R1
Moorhead, GB1
Khanna, KK2
Erker, L1
Schubert, R1
Yakushiji, H1
Barlow, C1
Larson, D1
Mitchell, JB1
Wynshaw-Boris, A1
Suzuki, K1
Kodama, S1
Watanabe, M1
Siliciano, JD1
Canman, CE1
Taya, Y4
Sakaguchi, K1
Appella, E1
Kastan, MB4
Nakagawa, K2
Tamai, K1
Yamaizumi, M1
Lakin, ND1
Hann, BC1
Jackson, SP1
Pandita, TK1
Lieberman, HB1
Lim, DS2
Dhar, S1
Zheng, W1
Kim, ST1
Xu, B1
Maser, RS1
Lin, J1
Petrini, JH1
Zhao, S1
Weng, YC1
Yuan, SS1
Lin, YT1
Hsu, HC1
Lin, SC1
Gerbino, E1
Song, MH1
Zdzienicka, MZ1
Gatti, RA1
Shay, JW1
Ziv, Y2
Lee, EY1
Wu, X1
Ranganathan, V1
Weisman, DS1
Heine, WF1
Ciccone, DN1
O'Neill, TB1
Crick, KE1
Pierce, KA1
Lane, WS1
Rathbun, G1
Livingston, DM1
Weaver, DT1
Delia, D1
Mizutani, S1
Panigone, S1
Tagliabue, E1
Fontanella, E1
Asada, M1
Yamada, T1
Prudente, S1
Saviozzi, S1
Frati, L1
Pierotti, MA1
Chessa, L1
Scott, SP1
Filippovitch, I1
Soronika, N1
Weber, B1
Yang, DQ1
Stewart, ZA1
Tang, LJ1
Pietenpol, JA1
Kishi, S1
Zhou, XZ1
Khoo, C1
Hill, DE1
Lu, KP1
Stewart, GS1
Stankovic, T1
Haites, N1
Kidd, AM1
Yoshida, M1
Hosoi, Y1
Miyachi, H1
Ishii, N1
Matsumoto, Y1
Enomoto, A1
Yamada, S1
Suzuki, N1
Ono, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Status of the Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis in Relation to Growth Failure, Body Weight and Neuroprotection in Children With Ataxia Telangiectasia[NCT01052623]Phase 424 participants (Anticipated)Interventional2010-01-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for serine and Ataxia Telangiectasia

ArticleYear
[Low-dose radiation effects and intracellular signaling pathways].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126, Issue:10

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA Damage; DNA-

2006

Other Studies

21 other studies available for serine and Ataxia Telangiectasia

ArticleYear
MRE11 stability is regulated by CK2-dependent interaction with R2TP complex.
    Oncogene, 2017, 08-24, Volume: 36, Issue:34

    Topics: Animals; Apoptosis Regulatory Proteins; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Protein

2017
RAD50 phosphorylation promotes ATR downstream signaling and DNA restart following replication stress.
    Human molecular genetics, 2014, Aug-15, Volume: 23, Issue:16

    Topics: Acid Anhydride Hydrolases; Ataxia Telangiectasia; Cell Line; Checkpoint Kinase 1; DNA Breaks, Double

2014
Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK.
    The EMBO journal, 2009, Dec-02, Volume: 28, Issue:23

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Carnitine O-Palmitoyltransferase; Cel

2009
Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity.
    Annals of neurology, 2004, Volume: 55, Issue:6

    Topics: Adult; Alanine; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Blood Cells; Blotting

2004
Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells.
    DNA repair, 2004, Jul-02, Volume: 3, Issue:7

    Topics: Amino Acid Sequence; Androstadienes; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins;

2004
Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A.
    The EMBO journal, 2004, Nov-10, Volume: 23, Issue:22

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catalytic Domain; Cell Cycle Proteins

2004
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
    Human molecular genetics, 2005, Jun-15, Volume: 14, Issue:12

    Topics: Animals; Antioxidants; Apoptosis; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cel

2005
DNA damage induces phosphorylation of the amino terminus of p53.
    Genes & development, 1997, Dec-15, Volume: 11, Issue:24

    Topics: Ataxia Telangiectasia; Binding Sites; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclin

1997
Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.
    Molecular and cellular biology, 1999, Volume: 19, Issue:4

    Topics: Acetylcysteine; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins;

1999
The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53.
    Oncogene, 1999, Jul-08, Volume: 18, Issue:27

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catalysis; Cell Cycle Proteins; DNA;

1999
Ionizing radiation activates the ATM kinase throughout the cell cycle.
    Oncogene, 2000, Mar-09, Volume: 19, Issue:11

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cell

2000
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
    Nature, 2000, Apr-06, Volume: 404, Issue:6778

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; DNA;

2000
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.
    Nature, 2000, May-25, Volume: 405, Issue:6785

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Chrom

2000
ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.
    Nature, 2000, May-25, Volume: 405, Issue:6785

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catalysis; Cell Cycle Proteins; Cell

2000
ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes.
    British journal of cancer, 2000, Volume: 82, Issue:12

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cell

2000
Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Cancer research, 2000, Jun-15, Volume: 60, Issue:12

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; BRCA1 Protein; Cell Cycle; Cell Cycle

2000
Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.
    Nature cell biology, 2000, Volume: 2, Issue:12

    Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Animals; Ataxia Telangiectasia; Ataxia Telangiectas

2000
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.
    Oncogene, 2001, Jan-04, Volume: 20, Issue:1

    Topics: Antineoplastic Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Pro

2001
Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks.
    The Journal of biological chemistry, 2001, Aug-03, Volume: 276, Issue:31

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Ataxia Telangiectasia; Ataxia Telangiectasia

2001
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
    The Journal of biological chemistry, 2001, Aug-10, Volume: 276, Issue:32

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Cells

2001
Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells.
    International journal of radiation biology, 2002, Volume: 78, Issue:6

    Topics: Androstadienes; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycl

2002